2026–2027:
Multi-site trials in Palau, UAE, and Japan; pilot medical tourism

2028–2029:
Phase III trials in UAE, Japan, and the U.S.; regulatory submissions

2030:
Global rollout with ~20,000 medical tourism patients annually